| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cullinan Oncology Inc (NASDAQ: CGEM)
CGEM Technical Analysis
2
| As on 9th Jun 2023 CGEM STOCK Price closed @ 13.11 and we RECOMMEND Buy for LONG-TERM with Stoploss of 12.91 & Strong Sell for SHORT-TERM with Stoploss of 14.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CGEMSTOCK Price
| Open | 13.07 | Change | Price | % |
| High | 13.21 | 1 Day | 0.11 | 0.85 |
| Low | 12.29 | 1 Week | 2.83 | 27.53 |
| Close | 13.11 | 1 Month | 3.44 | 35.57 |
| Volume | 296500 | 1 Year | -3.42 | -20.69 |
| 52 Week High 16.76 | 52 Week Low 7.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CGEM Daily Charts |
CGEM Intraday Charts |
Whats New @ Bazaartrend |
CGEM Free Analysis |
|
|
CGEM Important Levels Intraday
| RESISTANCE | 14.88 |
| RESISTANCE | 14.31 |
| RESISTANCE | 13.96 |
| RESISTANCE | 13.61 |
| SUPPORT | 12.61 |
| SUPPORT | 12.26 |
| SUPPORT | 11.91 |
| SUPPORT | 11.34 |
CGEM Forecast April 2024
| 4th UP Forecast | 20.86 |
| 3rd UP Forecast | 18.37 |
| 2nd UP Forecast | 16.84 |
| 1st UP Forecast | 15.3 |
| 1st DOWN Forecast | 10.92 |
| 2nd DOWN Forecast | 9.38 |
| 3rd DOWN Forecast | 7.85 |
| 4th DOWN Forecast | 5.36 |
CGEM Weekly Forecast
| 4th UP Forecast | 19.49 |
| 3rd UP Forecast | 17.44 |
| 2nd UP Forecast | 16.18 |
| 1st UP Forecast | 14.91 |
| 1st DOWN Forecast | 11.31 |
| 2nd DOWN Forecast | 10.04 |
| 3rd DOWN Forecast | 8.78 |
| 4th DOWN Forecast | 6.73 |
CGEM Forecast2024
| 4th UP Forecast | 34.62 |
| 3rd UP Forecast | 27.72 |
| 2nd UP Forecast | 23.46 |
| 1st UP Forecast | 19.19 |
| 1st DOWN Forecast | 7.03 |
| 2nd DOWN Forecast | 2.76 |
| 3rd DOWN Forecast | -1.5 |
| 4th DOWN Forecast | -8.4 |
Cullinan Oncology Inc ( NASDAQ USA Symbol : CGEM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CGEM Business Profile
Cullinan Management, Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Management, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: One Main Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service